The objective of this systematic review and meta-analysis was to examine the association between maternal chronic medical conditions (CMCs) and peripartum mental illness. MEDLINE, Embase, CINAHL, and PsycINFO were searched to September 2017. Data were extracted and quality was assessed using standardized instruments. We generated unadjusted and adjusted pooled odds ratios and 95% confidence intervals using DerSimonian and Laird random effects models. The review included 16 papers representing 12 studies and 1,626,260 women. CMCs overall were associated with peripartum mental illness overall (adjusted pooled odds ratios (aPOR) = 1.43, 95% confidence interval (CI): 1.25, 1.63). CMCs overall were associated with antepartum (aPOR = 1.41, 95% CI: 1.10, 1.81) and postpartum mental illness separately (aPOR = 1.44, 95% CI: 1.13, 1.85) and with peripartum depression (aPOR = 1.45, 95% CI: 1.25, 1.67) and anxiety separately (aPOR = 1.63, 95% CI: 1.35, 1.95). No studies examined bipolar or psychotic disorders. Diabetes (aPOR = 1.34, 95% CI: 1.07, 1.69), hypertension/heart disease (aPOR = 1.60, 95% CI: 1.05, 2.45), migraine (aPOR = 1.75, 95% CI: 1.20, 2.54), and other neurological disorders (aPOR = 1.45, 95% CI: 1.19, 1.77), but not asthma, were each associated with peripartum mental illness. Findings suggest that mental health resources should be integrated in medical settings where pregnant and postpartum women with CMCs are treated.
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Over 20% of women suffer from a mood, anxiety, or psychotic disorder in pregnancy or within 12 months of delivery (1) . Peripartum mental illness negatively affects mothers, infants, and families (2, 3), but it is underdiagnosed and undertreated, with 1 in 3 women with peripartum mental illness receiving psychiatric care (4) . Early identification of women at high risk could avert morbidity and societal cost (5) . Risk factors for peripartum mental illness include history of mental illness, stress, and poor social support (6) . However, despite knowledge of these factors, peripartum mental illness rates are not decreasing (5) . Greater understanding of high-risk groups is imperative.
One in 5 pregnancies is affected by chronic medical conditions (CMCs) such as metabolic, circulatory, and respiratory disease (7) . Growing evidence from nonperipartum populations suggests that persons with CMCs are at increased risk for mental illness (8) , with most studies focusing on mood disorders (9, 10) and a handful on anxiety and psychotic disorders (11) (12) (13) (14) . Psychosocial and biological factors, such as disease-management stress and chronic inflammation, are thought to explain the impact of CMC on mental-illness risk (15) (16) (17) . While it is plausible that this association would extend to peripartum populations, this has been minimally studied, and there has yet to be a synthesis of existing evidence. Integration of mental health care within antepartum and postpartum services facilitates prevention and reduces barriers to screening and treatment of peripartum mental illness (18) . If women with CMCs are at increased risk for peripartum mental illness, this could offer important opportunities for targeted prevention, early identification, and intervention.
The aim of this systematic review and meta-analysis was to examine the association between maternal CMCs and antepartum and postpartum mood, anxiety, and psychotic disorders.
METHODS

Search strategy
We used the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines (19) . In consultation with a research librarian, subject headings and keywords were developed for CMCs (chronic disease; metabolic, circulatory, respiratory, musculoskeletal, nervous system, digestive system, genitourinary, skin, and blood-related diseases), peripartum mental illness (antepartum, peripartum, and postpartum mood, anxiety, and psychotic disorders), and study design (cohort, case-control, and crosssectional studies) (Web Table 1 , available at https://academic.oup. com/aje). We searched MEDLINE, Embase, CINAHL, and Psyc-INFO from inception to September 2017. One author performed the initial search. We also hand-searched bibliographies of selected studies to identify studies missed in the database search.
Selection criteria
Titles and abstracts were reviewed by 2 authors. We included CMCs based on their prevalence in reproductive-aged women, cost, and policy relevance (20, 21) as well as potential mentalhealth risk (15) (16) (17) . Studies were required to: 1) examine, as an exposure, metabolic (diabetes, thyroid disease), circulatory (heart disease, hypertension), respiratory (asthma, chronic obstructive pulmonary disease), musculoskeletal (osteoarthritis, osteoporosis, rheumatoid arthritis), nervous system (epilepsy, migraine, multiple sclerosis), digestive system (Crohn's disease, ulcerative colitis), genitourinary (chronic kidney disease), skin (lupus, psoriasis), or blood-related (anemia) diseases (7); 2) examine, as an outcome, antepartum, peripartum, or postpartum depression, bipolar disorder, anxiety (generalized anxiety disorder, obsessive compulsive disorder, posttraumatic stress disorder), or psychotic disorders; 3) have a comparison group with no CMCs (cohort, case-control, or cross-sectional study); 4) be peer-reviewed; and 5) be written in English. We excluded studies of: 1) conditions that were not clearly chronic (diabetes not specified as prepregnancy, childhood diseases not specified as ongoing); 2) life-threatening conditions (cancer) or infectious diseases (HIV) because these have implications for maternal and fetal wellbeing that differ from other CMCs; 3) conditions affected by seasonality (allergies); and 4) obesity, because there is a meta-analysis of 62 studies on this topic (22) . All eligible studies were included in the qualitative synthesis; if multiple articles used the same data because of overlapping data sources, samples, and study periods, we selected for the quantitative synthesis the study with the highest quality.
Data extraction and management
Upon agreement on selected abstracts, full-text articles were retrieved. Data were independently extracted by 2 authors using a standardized form created a priori. Based on the Strengthening the Reporting of Observational Studies in Epidemiology statement (23), the form included location and study period; study design and data source; sample size and response, follow-up, and missing data rates; exclusion criteria; exposure and outcome definitions; and confounders. To calculate pooled effect estimates, we also extracted odds ratios and their 95% confidence intervals. Discrepancies were discussed until consensus was reached.
Quality assessment
A quality assessment of each article was conducted independently by 2 authors. We used an adapted version of the Effective Public Health Practice Project Quality Assessment tool, which is validated (24) and widely used (25) . Studies were rated on selection bias (representativeness, response rate), confounding, detection bias (outcome measure validity), and attrition bias (loss to follow-up, missing data) (Web Table 2 ). We identified confounders a priori that may be associated with CMC risk or severity and peripartum mental-illness risk (6): demographic factors, socioeconomic status, history of mental illness, stressful life events, and social support. Studies were rated overall as weak (≥2 categories with high risk of bias); moderate (1 category with high risk), or strong (no categories with high risk). Discrepancies were discussed until consensus was reached.
Data synthesis
We used DerSimonian and Laird random effects models (26) to calculate crude and adjusted pooled odds ratios for the association between: 1) CMCs overall and peripartum mental illness overall; 2) CMCs overall and antepartum and postpartum mental illness separately; 3) CMCs overall and peripartum mood, anxiety, and psychotic disorders separately; and 4) specific types of CMCs separately and peripartum mental illness overall. We examined the source of variance across studies by calculating I 2 and Q statistics (27) . For studies with a small I 2 value (<25%) and nonstatistically significant Q statistic, suggesting observed variation results from random variation and not real heterogeneity, we reestimated pooled odds ratios using fixed effects models (27) . We also reestimated pooled odds ratio excluding studies one by one to determine the impact of individual studies on results. Finally, we assessed publication bias for the adjusted association between CMCs overall and peripartum mental illness overall using a funnel plot and Egger test. A symmetrical, inverted funnel shape and nonsignificant Egger test, showing absence of asymmetry, suggest no publication bias (28) . We used the trim-and-fill method to ascertain the number of studies missing due to publication bias (29) . In additional analyses, we reestimated effects: 1) replacing chosen studies with others from among those using the same data; 2) replacing exposures or outcomes with variations tested by the original authors; 3) stratifying adjusted analyses according to whether key demographic and socioeconomic confounders (i.e., ethnicity, socioeconomic status) were included; and 4) stratifying analyses according to outcome measure (screening tests or diagnoses in administrative data). Analyses were conducted using Comprehensive Meta-Analysis (Biostat, Inc., Englewood, New Jersey). Figure 1 shows the article selection process. The search returned 5,127 articles after duplicate removal; 64 full-text articles were reviewed in detail. We excluded studies in which the exposure was not clearly chronic (n = 22); that had no comparison group (n = 6); and that examined mood (e.g., hostility) rather than mental illness (n = 5). Sixteen studies met our criteria and were included in the qualitative synthesis (30) (31) (32) (33) (34) (35) (36) (37) (38) (39) (40) (41) (42) (43) (44) (45) . Four studies from the United States used the same data, although each focused on different CMCs (35) (36) (37) 39) . Two Norwegian studies also used the same data (30, 43) . For the quantitative synthesis, we retained one study from each of these groups, for a total of 12 studies in the pooled association between CMCs overall and peripartum mental illness overall.
RESULTS
Search results
Characteristics of included studies
Web Table 3 describes the characteristics of the 16 studies included in the qualitative synthesis. Seven studies were conducted in the United States (34) (35) (36) (37) (38) (39) (40) , and the remainder in Canada (42), the United Kingdom (45), Finland (41), Sweden (44), Norway (30, 43) , Peru (33), Lebanon (32) , and Qatar (31) . Nine studies were prospective (30, 32, 37, 40) or retrospective cohort studies (34, 38, 42, 44, 45) , and 7 used cross-sectional designs (31, 33, 35, 36, 39, 41, 43) . Studies were similar in terms of exclusion criteria, which mainly related to ability to participate in research (34) (35) (36) (37) (38) (39) (40) . Only 1 study excluded women with a history of mental illness (31) . Studies ranged in size from 305 (40) to 707,701 women (44) . Studies measured multiple CMCs (n = 2) (32, 39); diabetes (n = 7) (34, 35, 37, 38, 40, 41, 44) ; thyroid disease (n = 1) (37); hypertension (n = 2) (36, 37) or heart disease (n = 2) (31, 37); asthma (n = 2) (37, 45); multiple sclerosis (n = 1) (42), epilepsy (n = 2) (30, 43), migraine (n = 2) (33, 37), or neurological conditions in general (n = 1) (37); and gastrointestinal disorders (n = 1) (37) . None examined the other CMCs included in our search strategy. Twelve studies measured antepartum (35, 36, 39, 41, 45) , postpartum (31-33, 37, 40, 44) , or peripartum depression (38) . One study did not distinguish between peripartum depression and anxiety (43); 2 measured peripartum depression and anxiety (30, 42) , and 1 measured postpartum depression, anxiety, and comorbidity (34) . None examined bipolar disorder or psychotic disorders. All studies controlled for confounders.
Quality of included studies
Web Table 4 summarizes the quality assessments. Studies were rated overall as strong (30, 35, 36, 43) , moderate (33, 34, 39, 41, 42, 44) , or weak (31, 32, 37, 38, 40, 45) . Regarding selection bias, 6 studies recruited women from tertiary centers, possibly representing high-risk groups (33, 35-37, 39, 40) . Response rates were ≥80% (33), 60%-79% (35, 36, 39) , or unreported (37, 40) . Studies that recruited women from more representative centers had response rates of ≥80% (31), <60% (30), or unreported (32, 43) . Six studies were population-based (34, 38, 41, 42, 44, 45) , but one used Medicaid data and excluded 77.6% of the cohort due to lack of continuous enrollment (38) . All studies controlled for confounders, but comprehensiveness varied. Several studies failed to control for demographic factors (31, 32, 34) . Notably, while minority and low-income women may be among those at highest risk for CMCs and mental illness, only 11 studies controlled for socioeconomic status (30, 32, 34-37, 39, 41-43, 45 ) and 6 for ethnicity (33, (35) (36) (37) (38) (39) . Studies also failed to control for history of mental 
Outcomes
Pooled analyses examined the association between: 1) CMCs overall and peripartum mental illness overall; 2) CMCs overall and antepartum and postpartum mental illness separately; 3) CMCs overall and peripartum mood, anxiety, and psychotic disorders separately; and 4) specific types of CMCs separately and peripartum mental illness overall. The US studies using the same data (35) (36) (37) 39) each contained data that could be included in at least 1 analysis. For a given analysis that could include multiple studies, we retained the highest-quality study. If an analysis included the 2 Katon et al. studies (2011, 2012) (35, 36) with the same quality rating, we retained the diabetes study (36) , because this was the most common CMC examined. For the Norwegian studies using the same data (30, 43) , one reported only a crude odds ratio (43), so we retained it in unadjusted pooled analyses and the other (30) in adjusted pooled analyses. Unadjusted analyses are presented in Web Figures 1-4 . Figure 2 shows the adjusted associations between CMCs overall and peripartum mental illness overall. The adjusted pooled odds ratio was 1.43 (95% confidence interval (CI): 1.25, 1.63; 12 studies, n = 1,626,260). There was heterogeneity in adjusted but not unadjusted analyses (Web Table 5 ). When we reestimated the pooled odds ratios excluding studies one by one, the association remained the same (Web Table 6 ). A funnel plot of the adjusted analysis was symmetrical (Egger test, P = 0.99; Web Figure 5) ; the trim-and-fill method imputed no missing studies, suggesting no publication bias. Figure 3 shows the adjusted associations between CMCs overall and antepartum and postpartum mental illness. The adjusted pooled odds ratios were 1.41 for antepartum (95% CI: 1.10, 1.81; 4 studies, n = 797,129) and 1.44 for postpartum mental illness (95% CI: 1.13, 1.85; 6 studies, n = 715,655). There was heterogeneity in the adjusted analyses for antepartum mental illness (Web Table 5 ). The adjusted analysis for antepartum mental illness and the unadjusted analysis for postpartum mental illness were sensitive to the removal of several studies (Web Table 6 ). Figure 4 shows the adjusted associations between CMCs overall and peripartum depression and anxiety disorders separately; there were no studies on bipolar or psychotic disorders. The pooled adjusted odds ratios were 1.45 for peripartum depression (95% CI: 1.25, 1.67; 11 studies, n = 1,624,796) and 1.63 for peripartum anxiety (95% CI: 1.35, 1.95; 2 studies, n = 107,167). Only Farr et al. (34) studied comorbid postpartum depression and anxiety (adjusted odds ratio (OR) = 1.0, 95% CI: 0.3, 2.7). There was heterogeneity in the adjusted peripartum depression analysis (Web Table 5 ). The analyses were not sensitive to removal of studies (Web Table 6 ). Figure 5 shows the unadjusted and adjusted associations between specific CMCs and peripartum mental illness. The pooled adjusted odds ratios were 1.34 for diabetes (95% CI: 1.07, 1.69; 6 studies, n = 1,237,817), 1.60 for hypertension or heart disease (95% CI: 1.05, 2.45; 2 studies, n = 3,777), 1.00 for asthma (95% CI: 0.41, 2.43; 2 studies, n = 282,422), 1.75 for migraine (95% CI: 1.20, 2.54; 2 studies, n = 3,197), and 1.45 for other neurological disorders (95% CI: 1.19, 1.77; 3 studies, n = 105,298). Only Katon et al. (37) studied thyroid (adjusted OR = 0.70, 95% CI: 0.34, 1.46) and gastrointestinal disorders (adjusted OR = 0.74, 95% CI: 0.42, 1.32). There was heterogeneity in adjusted diabetes and asthma analyses (Web Table 5 ). The hypertension or heart disease, asthma, and migraine analyses were sensitive to removal of some studies (Web Table 6 ).
Additional analyses
Results were similar when we replaced studies with others from among those using the same data and exposures or outcomes with variations tested by the original authors (Web Table 7 ). Several pooled odds ratios were completely attenuated when we stratified analyses according to whether or not ethnicity and socioeconomic status were controlled for (Web Table 8 ) and according to the type of outcome assessment used, likely due to smaller numbers of studies (Web Table 9 ).
DISCUSSION
This systematic review and meta-analysis, including 16 papers representing 12 unique studies, found that women with CMCs were at increased risk for peripartum mental illness. Women with diabetes, hypertension or heart disease, migraine, and other neurological disorders were at high risk; asthma, thyroid disease, and Figure 5 . Meta-analysis of the adjusted associations between specific types of chronic medical conditions separately and peripartum mental illness overall in studies conducted in multiple countries, 1988-2014. CI, confidence interval; OR, odds ratio.
gastrointestinal disorders showed no increased risk. No studies examined obstructive pulmonary disease, or musculoskeletal, digestive, genitourinary, skin, or blood-related diseases. Most studies focused on depression, but 2 suggested CMCs may increase risk for anxiety. One study suggested no association with comorbid depression and anxiety, and no studies examined bipolar or psychotic disorders. Because women with CMCs represent a significant proportion of the obstetrical population (7, 47) , prevention, early identification, and treatment of peripartum mental illness in these women could have a substantial positive impact.
To our knowledge, this is the first systematic review and metaanalysis to examine the association between CMCs and antepartum and postpartum mental illness. A prior review examined CMCs and postpartum depression (48) , citing the study by Chaaya et al. (32) included in our review and additionally examining a study on health-related quality of life and 2 on HIV that did not meet our inclusion criteria. Nonsignificant results in the latter 3 studies led the authors to conclude that there was no increased risk for postpartum depression among women with CMCs. However, the small number of studies in that review, along with its different scope, could explain the discrepancy in conclusions from ours. More broadly, meta-analyses of studies in nonperipartum populations have consistently shown increased risk of mental illness among individuals with CMCs. Secinti et al. (49) found that ongoing CMCs present since childhood were associated with adult depression (pooled OR = 1.31, 95% CI: 1.12, 1.54) and anxiety (pooled OR = 1.47, 95% CI: 1.13, 1.92). Others found similar associations in meta-analyses for diabetes (50) , hypertension (51) , and asthma (52) .
The mechanism for the association between CMCs and peripartum mental illness may relate to a combination of psychosocial and biological factors. The psychosocial hypothesis is that the mechanism relates to stress of treatment management, sleeplessness, or pain (15) . While we had no data on CMC severity, pooled odds ratios were slightly attenuated after accounting for factors that could influence one's resources for CMC management, such as age, income, and social support (53, 54) , as well as factors that could be on the causal path between CMCs and peripartum mental illness, such as pregnancy complications (55, 56) . However, even after controlling for these factors, increased risk remained. While this could be explained by residual confounding, the association between CMCs and peripartum mental illness could be more direct; many CMCs are associated with elevated proinflammatory cytokines, vascular pathology, or hypothalamic-pituitary-adrenal axis dysfunction, all of which are implicated in the pathophysiology of mental illness (16, 17) . Other mechanisms may include obesity associated with metabolic and circulatory disease (22, 57) , peripartum flares associated with some autoimmune CMCs (58), and shared genetic effects for some CMCs and mental illness (59) . The association may also be bidirectional. In nonperipartum populations, depression is posited as a risk factor for CMCs (60) . In our metaanalysis, Burgut et al. (31) excluded women with a history of mental illness, but none of the other studies made such exclusions, and only 3 controlled for history of mental illness (30, 32, 41) . Because mental illness is a remitting and relapsing disease, it is possible that observed risk reflects a new episode or ongoing mental illness, rather than onset. Nevertheless, higher prevalence of mental illness among postpartum women with CMCs has implications for screening and treatment. Future research should attend carefully to the timing of illness onset so that such programs are targeted appropriately.
Limitations
Strengths of our paper include the comprehensive literature search in multiple databases and the lack of evidence of publication bias. In general, findings were robust in sensitivity analyses. However, the statistical significance of analyses of CMCs overall and antepartum mental illness as well as hypertension or heart disease, asthma, and migraine and peripartum mental illness overall was sensitive to removal of some individual studies. Several stratified analyses (e.g., by control for ethnicity and socioeconomic status or by type of outcome assessment) also changed statistical significance, but this could be due to a smaller number of studies in such analyses. Interpretation of findings should also be considered in the context of the limitations of the studies themselves. Several studies had high risk of confounding (31, 34, 40, 45) , while all but 6 (30, 33, 39, 42, 43, 45) controlled for variables such as pregnancy complications that could be on the causal path between CMCs and peripartum mental illness. Although we used random effects models to account for heterogeneity, pooled adjusted estimates comprised studies with variable control for confounding, including studies with both over-and underadjustment. Outcome measures relied on screening tools or health-care encounters recorded in administrative data. While such measures do not capture clinical diagnoses per se, they do identify women whose symptoms warrant further assessment and, often, treatment and are therefore clinically relevant. Most studies did not distinguish between new and ongoing mental illness, but higher rates of ongoing mental illness among women with CMCs still indicate a need for improved treatment. The somewhat limited scope of exposures and outcomes identified in the literature search suggest future research should examine other types of CMCs and peripartum mental illness to fully understand the association. Studies focused almost entirely on peripartum depression. Anxiety is more prevalent than depression in the peripartum period (61) and has a significant negative impact on long-term maternal and infant wellbeing (62, 63) . Comorbid depression and anxiety is also common and is associated with increased treatment resistance and more severe symptoms (64) . Finally, while less prevalent, there is some evidence from nonperipartum populations to suggest elevated risk for bipolar or psychotic disorders among individuals with CMCs (11, 14) . Future studies should investigate these outcomes.
Implications and conclusion
Our systematic review and meta-analysis provides preliminary evidence to support integration of mental health prevention, screening, and intervention programs in obstetrical settings. Collaborative care improves patient outcomes for CMCs and mental illness, including better treatment adherence, quality of life, and clinical outcomes (65) . The psychosocial and biological mechanisms underlying the association between CMCs and peripartum mental illness demonstrate the utility of integration of care leading up to and during pregnancy. The preconception period may be an opportune time for peripartum mental-illness prevention through better CMC management and amelioration of CMC-associated stress. Screening and early intervention for peripartum mental illness in pregnancy and the early postpartum period could also avert morbidity. Uptake of integrated medical and psychiatric care in obstetrical settings is currently lacking (18) but can be improved through provision of appropriate resources (66) . Women with CMCs are strongly embedded in the health-care system, particularly around the time of pregnancy (7); integration of mental health care in obstetrical settings could have a substantial positive impact on the health of mothers, infants, and families.
